Unlocking the Secrets of Cardiac Development and Function: the Critical Role of FHL2

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2024 Oct 28

PMID 39466483

Authors

Tingting Jiang

Qun Zeng

Jing Wang

Affiliations

Soon will be listed here.

Abstract

FHL2 (Four-and-a-half LIM domain protein 2) is a crucial factor involved in cardiac morphogenesis, the process by which the heart develops its complex structure. It is expressed in various tissues during embryonic development, including the developing heart, and has been shown to play important roles in cell proliferation, differentiation, and migration. FHL2 interacts with multiple proteins to regulate cardiac development as a coactivator or a corepressor. It is involved in cardiac specification and determination of cell fate, cardiomyocyte growth, cardiac remodeling, myofibrillogenesis, and the regulation of HERG channels. Targeting FHL2 has therapeutic implications as it could improve cardiac function, control arrhythmias, alleviate heart failure, and maintain cardiac integrity in various pathological conditions. The identification of FHL2 as a signature gene in atrial fibrillation suggests its potential as a diagnostic marker and therapeutic target for this common arrhythmia.

References

Bach I . The LIM domain: regulation by association. Mech Dev. 2000; 91(1-2):5-17. DOI: 10.1016/s0925-4773(99)00314-7. View

Zhang J, Zeng Q, She M . The roles of FHL2 in cancer. Clin Exp Med. 2023; 23(7):3113-3124. DOI: 10.1007/s10238-023-01076-3. View

Kong Y, Shelton J, Rothermel B, Li X, Richardson J, Bassel-Duby R . Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation. 2001; 103(22):2731-8. DOI: 10.1161/01.cir.103.22.2731. View

Kadrmas J, Beckerle M . The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol. 2004; 5(11):920-31. DOI: 10.1038/nrm1499. View

Schmeichel K, Beckerle M . The LIM domain is a modular protein-binding interface. Cell. 1994; 79(2):211-9. DOI: 10.1016/0092-8674(94)90191-0. View

Habibe J, Clemente-Olivo M, Vries C . How (Epi)Genetic Regulation of the LIM-Domain Protein FHL2 Impacts Multifactorial Disease. Cells. 2021; 10(10). PMC: 8534169. DOI: 10.3390/cells10102611. View

Wixler V . The role of FHL2 in wound healing and inflammation. FASEB J. 2019; 33(7):7799-7809. DOI: 10.1096/fj.201802765RR. View

Kurakula K, Vos M, Logiantara A, Roelofs J, Nieuwenhuis M, Koppelman G . Deficiency of FHL2 attenuates airway inflammation in mice and genetic variation associates with human bronchial hyper-responsiveness. Allergy. 2015; 70(12):1531-44. DOI: 10.1111/all.12709. View

Kurakula K, Vos M, van Eijk M, Smits H, de Vries C . LIM-only protein FHL2 regulates experimental pulmonary Schistosoma mansoni egg granuloma formation. Eur J Immunol. 2015; 45(11):3098-106. DOI: 10.1002/eji.201545627. View

10.

Kurakula K, Vos M, Otermin Rubio I, Marinkovic G, Buettner R, Heukamp L . The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. PLoS One. 2014; 9(4):e94931. PMC: 3988136. DOI: 10.1371/journal.pone.0094931. View

11.

Ebrahimian T, Arfa O, Simeone S, Lemarie C, Lehoux S, Wassmann S . Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration. Circ Res. 2013; 114(1):114-23. DOI: 10.1161/CIRCRESAHA.113.301954. View

12.

Dahan J, Levillayer F, Xia T, Nouet Y, Werts C, Fanton dAndon M . LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression. Mol Cell Biol. 2017; 37(10). PMC: 5477553. DOI: 10.1128/MCB.00636-16. View

13.

Philippar U, Schratt G, Dieterich C, Muller J, Galgoczy P, Engel F . The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol Cell. 2004; 16(6):867-80. DOI: 10.1016/j.molcel.2004.11.039. View

14.

Hsieh F, Lu Y, Liau I, Chen C, Cheng C, Hsiao C . Zebrafish VCAP1X2 regulates cardiac contractility and proliferation of cardiomyocytes and epicardial cells. Sci Rep. 2018; 8(1):7856. PMC: 5959901. DOI: 10.1038/s41598-018-26110-3. View

15.

Neuman N, Ma S, Schnitzler G, Zhu Y, Lagna G, Hata A . The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone. J Biol Chem. 2009; 284(19):13202-12. PMC: 2676052. DOI: 10.1074/jbc.M900282200. View

16.

Steinhauser M, Lee R . Regeneration of the heart. EMBO Mol Med. 2011; 3(12):701-12. PMC: 3377117. DOI: 10.1002/emmm.201100175. View

17.

Kekupaa Knutson A, Williams A, Boisvert W, Shohet R . HIF in the heart: development, metabolism, ischemia, and atherosclerosis. J Clin Invest. 2021; 131(17). PMC: 8409592. DOI: 10.1172/JCI137557. View

18.

Uygur A, Lee R . Mechanisms of Cardiac Regeneration. Dev Cell. 2016; 36(4):362-74. PMC: 4768311. DOI: 10.1016/j.devcel.2016.01.018. View

19.

Gancz D, Perlmoter G, Yaniv K . Formation and Growth of Cardiac Lymphatics during Embryonic Development, Heart Regeneration, and Disease. Cold Spring Harb Perspect Biol. 2019; 12(6). PMC: 7263081. DOI: 10.1101/cshperspect.a037176. View

20.

Hill A, Riley P . Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2. Mol Cell Biol. 2004; 24(22):9835-47. PMC: 525463. DOI: 10.1128/MCB.24.22.9835-9847.2004. View